Advanced Oncotherapy PLC (LON:AVO)

Advanced Oncotherapy PLC (LON:AVO)


Share Price
47.00 p
Change
1.99999 (4.44 %)
Market Cap
£94.20 m
Proactive Investors - Run By Investors For Investors

Advanced Oncotherapy PLC

Advanced Oncotherapy is a specialist developer and provider of a breakthrough proton therapy system, the LIGHT system, which is the result of 25 years of work at CERN and ADAM.

Our focus is on developing and supplying technologies to maximise the destructive effect of radiation on tumours whilst minimising damage to the patient's healthy tissues.

Advanced Oncotherapy plc operates...

EPIC: AVO
Market: LSE:AVO
OTCBB:AONCF
FRA:R3I1
52-week High/Low: 60.00p / 33.00p
Sector: Health Care, Equipment & Services
Market Cap: £94.20 m
Website: www.avoplc.com
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of Advanced Oncotherapy PLC


Advanced Oncotherapy PLC Timeline

AVO is developing a proton beam system that blasts cancer called LIGHT. The initials stand for Linac Image Guided Hadron Technology. The company’s kit is cheaper and smaller than the current units, which are almost prohibitively expensive
Article

Advanced Oncotherapy on track

“We have exciting plans for the future commercialisation of the LIGHT system once completely developed, and our discussions with potential partners around the world are ongoing,” said chief executive Nicolas Serandour
Advanced Onco's LIGHT system has been designed to electronically control the fast delivery of protons to the tumour site. The company has developed a measurement system that measures the speed of the beam, which allows the system to measure the energy of each proton pulse

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use